Dr. Sulaiman Al-Habib Medical Services Group Co.
TTADAWUL:4013209.90
SAR
-5.30
(-2.46%)
ISIN
SA1510P1UMH1
Return %
Stock
S&P 500
1Y
-23.11
14.20
3Y
-7.94
81.12
5Y
17.79
68.34
Capital Structure
SAR
•
in mil. unless spec.Working Capital
SAR
•
in mil. unless spec.Growth Rates
SAR
•
in mil. unless spec.Quarterly Revenue
SAR
•
in mil. unless spec.Quarterly Earnings Per Share
SAR
•
in mil. unless spec.Quarterly Dividends Per Share
SAR
•
in mil. unless spec.Company Description
- CEO
- Faisal Abdullah Ali Al-Nassar
- Full Time Employees
- 10,475
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Al Olaya District Riyadh Riyadh Province Saudi Arabia 11372
- IPO Date
- Mar 17, 2020
- Website
- hmg.com
- Similar Companies
- Business
- Dr. Sulaiman Al Habib Medical Services Group Company (4013.SR) operates as a leading provider of integrated private healthcare services in Saudi Arabia and the GCC region. The company establishes, manages, and operates hospitals, general and specialized medical complexes, day surgery centers, primary care medical centers, and pharmaceutical facilities; it also delivers ancillary services including laboratory testing through MD Lab, healthcare IT solutions via its wholly-owned subsidiary Cloud Solutions Company (featuring the award-winning VIDA hospital information system), integrated healthcare technologies from Flow Medical Solutions, and revenue cycle management through Taswyat Management Company. Spanning over 60 medical specialties with centers of excellence in areas such as orthopedics, ophthalmology, and plastic surgery, the group serves more than three million patients annually across its network of over 20 hospitals and medical centers in Saudi Arabia, the United Arab Emirates, and Bahrain, supported by more than 1,900 beds, 1,370 clinics, and a network of pharmacies. Founded in 1993 and headquartered in Riyadh, Saudi Arabia, the company maintains a workforce exceeding 13,000 employees and aligns its expansions with Saudi Vision 2030 to enhance private sector participation in healthcare. In recent developments, the group has aggressively expanded its capacity by approximately 80% from FY23 levels through FY24 and H1 FY25, adding around 580 beds via three new facilities including Al Sahafa Hospital, Gharb Jeddah Women's Health Hospital, and upcoming sites in Al-Kharj and North Jeddah's Alhamra, while reporting net income growth of 6.5% year-over-year to SAR 591 million in Q2 2025. In November 2024, Dr. Sulaiman Al Habib Medical Services Group reinforced its strategic partnership with GE HealthCare, investing in advanced MRI systems, over 1,000 patient monitors and cardiology equipment, ultrasound solutions, and the global debut of the Portrait VSM Vital Signs Monitor (500 units) across its network to bolster diagnostics, patient monitoring, and alignment with Vision 2030 healthcare goals. These initiatives, including ongoing construction of three additional facilities and projected revenue/net income CAGRs of 13.2%/17.0% through FY29, underscore the company's focus on technological innovation, operational ramp-ups, and regional growth.